Blumenfeld, Z., & Ruach, M. (1992). Early pregnancy wastage: the role of repetitive human chorionic gonadotropin supplementation during the first 8 weeks of gestation. Fertility and Sterility, 58(1), 19-23. https://doi.org/10.1016/s0015-0282(16)55130-9
Blumenfeld Z, Ruach M. Early pregnancy wastage: the role of repetitive human chorionic gonadotropin supplementation during the first 8 weeks of gestation. Fertil Steril. 1992;58(1):19-23. doi:10.1016/s0015-0282(16)55130-9
Blumenfeld, Zeev, and Meir Ruach. "Early pregnancy wastage: the role of repetitive human chorionic gonadotropin supplementation during the first 8 weeks of gestation." Fertility and Sterility, vol. 58, no. 1, 1992, pp. 19-23.
For EndNote, Zotero or Mendeley:
Open access
Free to read
No reuse license
Free to read at the publisher (reported by Unpaywall and OpenAlex, not verified by RRM Academy)
Author affiliations
1 institution
Technion – Israel Institute of Technology03qryx823
Linked to ROR, the Research Organization Registry
RRM Academy Synopsis
Women given hCG in early pregnancy miscarried less often than controls
Miscarriage ended about 2 in 10 hCG-treated pregnancies and 5 in 10 untreated ones. This 1992 Israeli trial followed 447 pregnancies in infertile women at high risk. Assignment was partly randomized.
Pregnancies ending in miscarriage: Given hCG, 17.3 in 100; No hCG, 49 in 100. Source: Blumenfeld Z et al., 1992, PMID 1624004.Study at a glance, partly randomized of 447 pregnancies: Women given hCG in early pregnancy miscarried less often than controls. Source: Blumenfeld Z et al., 1992, PMID 1624004.
Key Findings
Miscarriage ended 43 of 249 pregnancies given hCG (17.3%) and 97 of 198 in the control group (49%), P < 0.01.
After hMG/hCG ovulation induction, 20 of 94 pregnancies with hCG (21.3%) and 28 of 66 without (42.4%) ended in miscarriage, P < 0.05.
After clomiphene citrate ovulation induction, 15 of 95 pregnancies with hCG (15.8%) and 22 of 49 without (44.8%) ended in miscarriage, P < 0.01.
Among 143 spontaneous pregnancies in women with previous repeated abortions, 8 of 60 with hCG (13.3%) and 47 of 83 without (56.6%) ended in miscarriage, P < 0.001.
Seventy-nine of the 447 pregnancies (18%) were in groups the women chose themselves. Their miscarriage rates showed no significant difference from the randomized groups.
Interpretation
This study followed 447 pregnancies in infertile women at high risk for miscarriage. The women were grouped by risk. The authors presumed luteal dysfunction was the common cause behind giving hCG. The findings cover women after hMG/hCG or clomiphene citrate ovulation induction and women with previous repeated miscarriage. The authors note that their explanations for how hCG works remain theoretical and await validation. The findings support larger studies of this approach.
RRM Context
A restorative evaluation checks luteal function in each woman before treatment. Cycle charting can document the luteal phase. NaProTechnology, for example, defines luteal phase defects by charted criteria.
Our editorial summary of this paper, not the article's abstract.
Abstract
Objective
To determine if repetitive administration of hCG causes decreased pregnancy wastage rates in patients who are at a high risk of luteal inadequacy.
Design
Ovulation induction using human menopausal gonadotropin (hMG)/human chorionic gonadotropin (hCG) or clomiphene citrate (CC) is associated with luteal phase defects that may cause increased pregnancy wastage. An increased risk of abortion exists also in pregnancies in patients with previous repeated miscarriage, women older than 37 years, and various causes of infertility such as hyperprolactinemia. Because the presumed common denominator to the increased rate of pregnancy wastage in all these cases is luteal dysfunction, repetitive hCG administration, 2,500 U two times weekly, was carried out between the 4th and 8th week of gestation in 249 cases of ovulation induction and/or previous abortions, whereas 198 gestations served as controls (no hCG administration).
Results
In the hCG treatment group, 43 ended in miscarriage (17.3%) versus 97 abortions in the control group (49%, P less than 0.01). In 160 cases of hMG/hCG generated gestations, 94 received hCG and 66 did not. The pregnancy wastage rates were 21.3% and 42.4%, respectively (P less than 0.05). In 144 cases of CC/hCG-induced pregnancies, 95 received hCG and 49 served as controls. The respective abortion rates were 15.8% and 44.8% (P less than 0.01). The remaining 143 spontaneous conceptions occurred in infertile patients with previous repeated abortions. In 60 of these conceptions, hCG was administered during the first 4 weeks of gestation and 83 cases served as control. The pregnancy wastage rates were 13.3% versus 56.6%, respectively (P less than 0.001).
Conclusion
Repetitive administration of hCG during the early gestation in cases that are at high risk of luteal inadequacy may significantly decrease the pregnancy wastage rate.
Miscarriage affects approximately 15% of clinically confirmed pregnancies. Recurrent pregnancy loss (RPL), defined as two or more clinical losses, affects 2 to 5% of couples. Most causes are diagnosable and treatable. This guide covers what the standard workup misses, what RRM-trained clinicians evaluate, and what outcomes look like after cause-based treatment.